IL6 and obesity disorder: Interleukin‐6 (IL‐6), a major driver for secondary inflammation in obesity and diabetes,[35] was increased in stimulated macrophages after SP exposure as opposed to vehicle‐treated or unstimulated macrophages (Figure 1D; Figure S2A, Supporting Information).